Weekly Digest – June 2025 Weekly Digest – June 2025 23 June 2025: DATROWAY approved in the U.S. as first TROP2 directed therapy for patients with previously treated advanced EGFR-mutated non-small cell lung cancer DATROWAY (datopotamab deruxtecan-dlnk) received accelerated approval in […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id